Search News Archives
Conferences | Events
First large scale study of cocaine users leads to breakthrough in drug testing
Scientists from the University of Surrey have developed a rapid and highly sensitive fingerprint test that can take just seconds to confirm whether someone has used cocaine.
This new breakthrough, published in Clinical Chemistry, comes as a result of the first large scale study of cocaine users and could pave the way for the detection of a range of other Class A substances.The research was carried out with partners from the Netherlands Forensic Institute and Intelligent Fingerprinting.
The team, led by Dr Catia Costa and Dr Melanie Bailey from the University of Surrey, developed a new technique to analyse the levels of cocaine detected in the fingerprints. They used chromatography paper to take the sample as part of a technique known as paper spray mass spectrometry.
The study involved taking fingerprints from a group of patients seeking treatment at drug rehabilitation centres, as well as a larger group not known to be drug users. All of those taking part washed their hands before the test in a variety of ways, and then samples were collected on the prepared chromatography paper. The fingerprint is developed using chemicals, so that the ridges of the fingerprint (and therefore the identity of the donor) can be established prior to analysis. When someone has taken cocaine, they excrete traces of benzoylecgonine and methylecgonine as they metabolise the drug, and these chemical indicators are present in fingerprint residue. Importantly, the traces can still be detected even after handwashing.
According to the National Statistics Office, 1 in 12 adults aged 16 to 59 (around 2.7 million people) had taken illicit drugs in 2015/16. There were also over 8,500 people who were admitted to hospital after being diagnosed with drug-related mental health and behavioural disorder. In 2015, there were almost 2,500 deaths related to drug misuse – an increase of 10 per cent on 2014.
Dr Costa said: “Paper spray mass spectrometry is gaining increasing popularity in forensic circles because it is incredibly sensitive and is very easy to set up a testing system – the units will save laboratories time.
“This is the first time it has ever been used to detect the presence of drugs in fingerprints, and our results show the technique was 99% effective in detecting cocaine use among the patients.”
Dr Bailey said: “This is a real breakthrough in our work to bring a real time, non-invasive drug-testing method to the market that will provide a definitive result in a matter of minutes – we are already working on a 30 second method.”
“And, as with previous methods we have developed, it is non-invasive, hygienic and can’t be faked – by the nature of the test, the identity of the subject, and their drug use, is all captured within the sample itself.”
“This exciting research clearly demonstrates the important role that fingerprints can play in simplifying drug screening, and complements our own parallel developments in portable, point-of-use diagnostic tests. These activities confirm the value of a fingerprint as a diagnostic matrix,” added Dr Jerry Walker, Intelligent Fingerprinting’s CEO.
“We have supported the University of Surrey research programmes for the last four years, and Dr Bailey and her team have shown time and again that they are the world’s leading group in fingerprint diagnostics research using mass spectrometry. We congratulate them in continuing to expand knowledge in the revolutionary field of fingerprint-based diagnostics.”
It is anticipated that this technology could see the introduction of drug tests for law enforcement agencies to use within the next decade. Drug testing is used routinely by probation services, prisons, courts and other law enforcement agencies. However, traditional testing methods have limitations. Where bodily fluids are tested, there can be biological hazards and often a requirement for particular storage and disposal methods.
The University of Surrey is one of the UK’s top higher education institutions and was recognised as the University of the Year in The Times and Sunday Times Good University Guide 2016. With 125 years of academic heritage since our founding in Battersea, and 50 years of world-class teaching and research in Guildford, the University of Surrey is the intellectual home for more than 15,200 students, 100,000 alumni and 2,800 staff.
Freedom of thought, pursuit of academic excellence, and the advancement and application of knowledge underpin the wonderful things happening here. Our mission is to transform lives and enrich society through outstanding teaching and learning, pioneering research and impactful innovation.
The University of Surrey has been recognised by three Queen’s Anniversary Prizes for Further and Higher Education and is a destination of choice for higher learning in subjects ranging from Engineering to the Arts. As a global University, we are proud of our strong partnerships with internationally leading institutions and businesses, while being firmly engaged with our local community in Guildford and Surrey. We are committed to educating the next generation of professionals and leaders, and to providing thought leadership and innovation to address global challenges and contribute to a better tomorrow for the world.
Intelligent Fingerprinting’s unique fingerprint-based portable Drug Screening System is set to revolutionise the way drug screening is carried out across a range of sectors. The distinctive Intelligent Fingerprinting technology, which works by analysing the sweat from a fingerprint sample, enables non-invasive, cost-effective screening for multiple drug groups in less than 10 minutes (currently amphetamines, cannabis, cocaine and opiates).
Intelligent Fingerprinting has attracted worldwide interest in its technology from a wide range of drug-screening markets including the criminal justice arena, drug rehabilitation centres, prisons and occupational health services. The technique has potential for many other uses including healthcare diagnostics and homeland security applications.
The company’s ground-breaking technology detects drug use by analysing chemicals, known as metabolites, contained in the minute traces of sweat found in a fingerprint. (Metabolites are chemicals produced by the body as a result of normal metabolic processes.) The Intelligent Fingerprinting Drug Screening System looks for the presence of specific drugs or drug metabolites in the test subject’s fingerprint sweat sample and, if detected, identifies which drugs have been consumed.
Intelligent Fingerprinting also works closely with universities, measurement and testing bodies – including organisations such as the LGC, University of Surrey and the UK National Measurement Laboratory and Designated Institute for chemical and bio-measurement - to support the wider development of fingerprint-based drug screen analysis methods and future research into fingerprints as a diagnostic matrix.
Founded in 2007, Intelligent Fingerprinting is a spin-out company from the University of East Anglia (UEA). The company is based in Cambridge, England and currently employs around 30 people. Since 2012 Intelligent Fingerprinting has raised £11.23m in funding from a consortium of private UK and US-based investors, as well as government funding for pilot studies within the UK’s National Health Service and Coroners’ services.